PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 21 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous extract of S. coccinea leaf (AESL) inhibited streptozotocin-induced increase in serum lipid peroxidation, aspartate transaminase, alanine transaminase, and lactate dehydrogenase in rats [PMID:34052674].
AESL ameliorated pathological changes in isoproterenol-induced myocardial infarction heart muscles and ECG patterns in rats [PMID:41550788].
AESL provided 35-80% protection against selenite-induced cataractogenesis and prevented apoptosis in the rat lens [PMID:41550788].
AESL showed ameliorating effects on complete Freund's adjuvant-induced arthritis in Wistar rats [PMID:41550788].
Methanol extracts of S. coccinea showed antifungal activity against at least one strain of Candida species with MIC values < 31.25µg/mL [PMID:28603107].
Evidence summary
PubMed sources
- 1.PMID: 41640995 (2026) — Salvia coccinea and Apigenin: A Natural Treasure of Lamiaceae in Pharmacological Innovation. · Food science & nutrition
- 2.PMID: 41550788 (2023) — Potential therapeutic effect of Salvia coccinea leaf extract in chronic disorders: Myocardial infarction, cataract, and arthritis in rat. · Pharmaceutical science advances
- 3.PMID: 35005949 (2021) — Biosynthesis of Silver Nanoparticles from Leaf Extract of Salvia coccinea and Its Effects of Anti-inflammatory Potential in Human Monocytic THP-1 Cells. · ACS applied bio materials
- 4.PMID: 29843455 (2018) — Changes in Photosynthetic Pigments, Total Phenolic Content, and Antioxidant Activity of Salvia coccinea Buc'hoz Ex Etl. Induced by Exogenous Salicylic Acid and Soil Salinity. · Molecules (Basel, Switzerland)
- 5.PMID: 34052674